Early gene m18, a novel player in the immune response to murine cytomegalovirus

Journal of General Virology

Volumn 83, Issue 2, 2002, Pages 311-316

  Holtappels, Rafaela ^a   Grzimek, Natascha K A ^a   Thomas, Doris ^a   Reddehase, Matthias J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN; PEPTIDE; VIRUS PROTEIN;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GENETIC CODE; HAPLOTYPE; IMMEDIATE EARLY GENE; IMMUNOGENICITY; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS INFECTIVITY; VIRUS REPLICATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0036166644     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-2-311     Document Type: Article

References (33)

1. Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells
2. A subset of viral transcripts packaged within human cytomegalovirus particles
3. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18
4. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: More questions than answers
5. Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins
6. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase
7. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment
8. Molecular cloning and physical mapping of murine cytomegalovirus DNA
9. Immune evasion by cytomegalovirus-survival strategies of a highly adapted opportunist
10. Cytomegaloviral control of MHC class I function in the mouse
11. Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates
12. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells
13. d-restricted antigenic peptide encoded by murine cytomegalovirus early gene M84
14. lo memory-effector cell pool during latent murine cytomegalovirus infection of the lungs
15. Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologues of human cytomegalovirus tegument protein ppUL83 (pp65)
16. d haplotype
17. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface
18. d class I major histocompatibility complex molecules determines their antigenic structure
19. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses
20. In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83)
21. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65)
22. MHC ligands and peptide motifs
23. Analysis of the complete DNA sequence of murine cytomegalovirus
24. The immunogenicity of human and murine cytomegaloviruses
25. Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes
26. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes
27. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease
28. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation
29. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells
30. Topology prediction for helical transmembrane proteins at 86% accuracy
31. Induction of bystander T cell proliferation by viruses and type I interferon in vivo
32. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments
33. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyses the retention of MHC class I molecules